GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid.

[1]  J. Mocco,et al.  Dehydroascorbic acid, a blood–brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Rocha,et al.  Diphenyl diselenide and ascorbic acid changes deposition of selenium and ascorbic acid in liver and brain of mice. , 2001, Pharmacology & toxicology.

[3]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[4]  M. Wajner,et al.  Methylmalonate administration decreases Na+,K+‐ATPase activity in cerebral cortex of rats , 2000, Neuroreport.

[5]  M. Beal.  Energetics in the pathogenesis of neurodegenerative diseases , 2000, Trends in Neurosciences.

[6]  M. Rice.  Ascorbate regulation and its neuroprotective role in the brain , 2000, Trends in Neurosciences.

[7]  M. Wajner,et al.  Propionic and L‐methylmalonic acids induce oxidative stress in brain of young rats , 2000, Neuroreport.

[8]  G. Zeevalk,et al.  Oxidative stress during energy impairment in mesencephalic cultures is not a downstream consequence of a secondary excitotoxicity , 2000, Neuroscience.

[9]  M. Wajner,et al.  Ascorbic acid and alpha-tocopherol attenuate methylmalonic acid-induced convulsions. , 1999, Neuroreport.

[10]  Taro Tokui,et al.  A family of mammalian Na+-dependent L-ascorbic acid transporters , 1999, Nature.

[11]  J. Palermo-neto,et al.  Kinetic analysis of GM1 effects on haloperidol-induced dopaminergic supersensitivity. , 1999, General pharmacology.

[12]  D. Cassarino,et al.  An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration , 1999, Brain Research Reviews.

[13]  V. Maupoil,et al.  Studies by electron paramagnetic resonance of the importance of iron in the hydroxyl scavenging properties of ascorbic acid in plasma: Effects of iron chelators , 1998, Fundamental & clinical pharmacology.

[14]  M. Rice,et al.  Estrogen-dependent modulation of rat brain ascorbate levels and ischemia-induced ascorbate loss , 1998, Brain Research.

[15]  I. Silver,et al.  Methylmalonate toxicity in primary neuronal cultures , 1998, Neuroscience.

[16]  S. Tufik,et al.  Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover. , 1998, Life sciences.

[17]  J. Baselga,et al.  Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. , 1997, The Journal of clinical investigation.

[18]  B. Sabel,et al.  The Role of Striatal Glutamatergic System in Haloperidol-Induced Dopamine Receptor Supersensitivity and Effects of Monosialoganglioside GM1 , 1997, Pharmacology Biochemistry and Behavior.

[19]  A. Cuello,et al.  Responses of cortical noradrenergic and somatostinergic fibres and terminals to adjacent strokes and subsequent treatment with NGF and/or the ganglioside GM1 , 1997, Journal of neuroscience research.

[20]  J. Palermo-neto,et al.  Effects of monosialoganglioside on a new model of tardive dyskinesia , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  R. H. Silva,et al.  Effects of long-term ganglioside GM1 administration on a new discriminative avoidance test in normal adult mice. , 1997, Psychopharmacology.

[22]  J. Palermo-neto,et al.  Repeated monosialoganglioside administration attenuates behavioral sensitization to amphetamine , 1997, Brain Research.

[23]  M. Rice,et al.  Enhanced oxidative stress in female rat brain after gonadectomy , 1996, Brain Research.

[24]  R. Camarini,et al.  Monosialoganglioside attenuates the excitatory and behavioural sensitization effects of ethanol. , 1996, European journal of pharmacology.

[25]  A. G. Nasello,et al.  Effect of ganglioside (GM1) on memory in senescent rats , 1996, Neurobiology of Aging.

[26]  J. Schulz,et al.  Striatal Malonate Lesions Are Attenuated in Neuronal Nitric Oxide Synthase Knockout Mice , 1996, Journal of neurochemistry.

[27]  M. Wajner,et al.  Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms , 1996, Brain Research.

[28]  S. Bondy,et al.  Effect of an NMDA receptor antagonist and a ganglioside GM1 derivative upon ethanol-induced modification of parameters of oxidative stress in several brain regions , 1996, Brain Research.

[29]  J. Vera,et al.  Resolution of the Facilitated Transport of Dehydroascorbic Acid from Its Intracellular Accumulation as Ascorbic Acid (*) , 1995, The Journal of Biological Chemistry.

[30]  C. Epstein,et al.  3‐Nitropropionic Acid Neurotoxicity Is Attenuated in Copper/Zinc Superoxide Dismutase Transgenic Mice , 1995, Journal of neurochemistry.

[31]  M. Rice,et al.  Gender differences in cerebral ascorbate levels and ascorbate loss in ischemia , 1995, Neuroreport.

[32]  J. Palermo-neto,et al.  Effects of monosialoganglioside on dopaminergic supersensitivity. , 1995, Life sciences.

[33]  B. Rosen,et al.  Involvement of Free Radicals in Excitotoxicity In Vivo , 1995, Journal of neurochemistry.

[34]  R. Reiter,et al.  Oxidative processes and antioxidative defense mechanisms in the aging brain 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  B. Rosen,et al.  Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate , 1994, Annals of neurology.

[36]  Y. Tyurina,et al.  Gangliosides in Postischemic Cellular Dysfunctions , 1994, Annals of the New York Academy of Sciences.

[37]  J. Greene,et al.  The endogenous cofactors, thioctic acid and dihydrolipoic acid, are neuroprotective against NMDA and malonic acid lesions of striatum , 1994, Neuroscience Letters.

[38]  N. Maulik,et al.  Reduction of Myocardial Ischemic Reperfusion Injury by Sialylated Glycosphingolipids, Gangliosides , 1993, Journal of cardiovascular pharmacology.

[39]  R. Grünewald.  Ascorbic acid in the brain , 1993, Brain Research Reviews.

[40]  M. Wajner,et al.  Inhibition of succinate dehydrogenase and β-hydroxybutyrate dehydrogenase activities by methylmalonate in brain and liver of developing rats , 1993, Journal of Inherited Metabolic Disease.

[41]  M. Levine,et al.  Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. , 1991, The American journal of clinical nutrition.

[42]  H. Padh.  Cellular functions of ascorbic acid. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[43]  G. Rodriguez,et al.  Sex Differences in Regional Cerebral Blood Flow , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[45]  R. Brady,et al.  Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Kaufman.  Coenzymes and hydroxylases: ascorbate and dopamine-beta-hydroxylase; tetrahydropteridines and phenylalanine and tyrosine hydroxylases. , 1966, Pharmacological reviews.

[47]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[48]  R. Yu,et al.  Role of sphingolipid-mediated cell death in neurodegenerative diseases. , 1998, Journal of lipid research.

[49]  K. Bagchi,et al.  Evaluation of tissue ascorbic acid status in different hormonal states of female rat. , 1993, Life sciences.

[50]  S. Trojan,et al.  Ascorbic acid in the brain. , 1991, Physiological research.

[51]  A. Carolei,et al.  Monosialoganglioside GM1 in cerebral ischemia. , 1991, Cerebrovascular and brain metabolism reviews.

[52]  R. Ghidoni,et al.  Fundamentals of Brain Ganglioside Biosynthesis , 1987 .

[53]  S. Seifter,et al.  The biochemical functions of ascorbic acid. , 1986, Annual review of nutrition.

[54]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[55]  R. Chalmers,et al.  Disorders of propionate and methylmalonate metabolism , 1982 .

[56]  S. Hakomori.  Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. , 1981, Annual review of biochemistry.

[57]  M. Nath,et al.  Effect of male sex hormones on ascorbic acid metabolism in rats. , 1974, Journal of nutritional science and vitaminology.